BlackRock Institutional Trust’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$17K Hold
83
﹤0.01% 3773
2016
Q3
$22K Hold
83
﹤0.01% 3803
2016
Q2
$25K Hold
83
﹤0.01% 3806
2016
Q1
$35K Hold
83
﹤0.01% 3820
2015
Q4
$41K Hold
83
﹤0.01% 3827
2015
Q3
$97K Hold
83
﹤0.01% 3736
2015
Q2
$146K Hold
83
﹤0.01% 3673
2015
Q1
$97K Sell
83
-14
-14% -$16.6K ﹤0.01% 3707
2014
Q4
$97K Hold
97
﹤0.01% 3714
2014
Q3
$131K Buy
97
+56
+137% +$80.2K ﹤0.01% 3656
2014
Q2
$70K Buy
41
+35
+583% +$66.6K ﹤0.01% 3787
2014
Q1
$15K Buy
+6
New +$15.4K ﹤0.01% 3888

Other funds holding VYNT

BlackRock Institutional Trust's VYNT Position: Q4 2016 in Review

BlackRock Institutional Trust held its Vyant Bio, Inc. Common Stock (VYNT) position steady in Q4 2016 at 83 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #3773.

BlackRock Institutional Trust first reported a position in VYNT in Q1 2014 and has held it in 12 quarters since. The position peaked at $146K in Q2 2015. 29 funds tracked by Wall St. Rank hold VYNT as of Q4 2016.

  • BlackRock Institutional Trust held 83 shares of Vyant Bio, Inc. Common Stock worth $17K as of Q4 2016.
  • BlackRock Institutional Trust left its Vyant Bio, Inc. Common Stock share count unchanged in Q4 2016.
  • Vyant Bio, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3773 holding.
  • BlackRock Institutional Trust first reported a position in Vyant Bio, Inc. Common Stock in Q1 2014 and has held it in 12 quarters since.
  • BlackRock Institutional Trust's Vyant Bio, Inc. Common Stock position peaked at $146K in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.